Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15039 | 666 | 48.1 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
483 | 14947 | GANGLIOSIDES//SIALYLTRANSFERASE//SIALIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SIGLEC | Author keyword | 62 | 69% | 8% | 53 |
2 | SIGLECS | Author keyword | 46 | 71% | 6% | 37 |
3 | SIGLEC 8 | Author keyword | 41 | 100% | 2% | 15 |
4 | CD22 | Author keyword | 28 | 38% | 9% | 59 |
5 | SIALOADHESIN | Author keyword | 25 | 58% | 4% | 29 |
6 | SIGLEC F | Author keyword | 22 | 81% | 2% | 13 |
7 | WELLCOME TRUST BIO DUNDEE | Address | 18 | 89% | 1% | 8 |
8 | HB227 | Author keyword | 9 | 83% | 1% | 5 |
9 | GLYCOBIOL TRAINING | Address | 9 | 17% | 7% | 46 |
10 | SIGLEC 9 | Author keyword | 8 | 70% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SIGLEC | 62 | 69% | 8% | 53 | Search SIGLEC | Search SIGLEC |
2 | SIGLECS | 46 | 71% | 6% | 37 | Search SIGLECS | Search SIGLECS |
3 | SIGLEC 8 | 41 | 100% | 2% | 15 | Search SIGLEC+8 | Search SIGLEC+8 |
4 | CD22 | 28 | 38% | 9% | 59 | Search CD22 | Search CD22 |
5 | SIALOADHESIN | 25 | 58% | 4% | 29 | Search SIALOADHESIN | Search SIALOADHESIN |
6 | SIGLEC F | 22 | 81% | 2% | 13 | Search SIGLEC+F | Search SIGLEC+F |
7 | HB227 | 9 | 83% | 1% | 5 | Search HB227 | Search HB227 |
8 | SIGLEC 9 | 8 | 70% | 1% | 7 | Search SIGLEC+9 | Search SIGLEC+9 |
9 | GLYCAN LIGANDS | 6 | 80% | 1% | 4 | Search GLYCAN+LIGANDS | Search GLYCAN+LIGANDS |
10 | SIGLEC 1 | 5 | 55% | 1% | 6 | Search SIGLEC+1 | Search SIGLEC+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SIALOADHESIN FAMILY | 75 | 91% | 5% | 31 |
2 | CD22 DEFICIENT MICE | 57 | 53% | 11% | 75 |
3 | ACID BINDING RECEPTOR | 57 | 70% | 7% | 47 |
4 | CD33 RELATED SIGLECS | 56 | 84% | 5% | 31 |
5 | CD22 | 47 | 41% | 13% | 89 |
6 | SIALOADHESIN | 38 | 44% | 10% | 64 |
7 | ADHESION MOLECULE CD22 BETA | 36 | 83% | 3% | 20 |
8 | IMMUNOGLOBULIN LIKE LECTINS | 23 | 86% | 2% | 12 |
9 | I TYPE LECTINS | 21 | 57% | 4% | 25 |
10 | HUMAN EOSINOPHIL APOPTOSIS | 19 | 74% | 2% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Siglecs and their roles in the immune system | 2007 | 495 | 122 | 78% |
Siglec-mediated regulation of immune cell function in disease | 2014 | 16 | 138 | 72% |
Siglecs and Immune Regulation | 2012 | 55 | 161 | 70% |
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease | 2014 | 11 | 50 | 78% |
Siglecs - the major subfamily of I-type lectins | 2006 | 162 | 236 | 67% |
Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? | 2011 | 46 | 62 | 66% |
Siglecs, sialic acids and innate immunity | 2001 | 210 | 47 | 77% |
Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling | 2002 | 191 | 56 | 80% |
CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions | 2009 | 53 | 114 | 71% |
Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions | 2012 | 22 | 88 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WELLCOME TRUST BIO DUNDEE | 18 | 89% | 1.2% | 8 |
2 | GLYCOBIOL TRAINING | 9 | 17% | 6.9% | 46 |
3 | WELLCOME TRUST BIO | 7 | 12% | 8.0% | 53 |
4 | BIOCHEM HEIDELBERG | 5 | 63% | 0.8% | 5 |
5 | MED 0687 | 1 | 50% | 0.3% | 2 |
6 | SHEMYAKIN OVCHINNOKOV BIOORGAN CHEM | 1 | 50% | 0.3% | 2 |
7 | CELL SIGNALLING IMMUNOL | 1 | 10% | 1.7% | 11 |
8 | NEURAL REGENERAT GRP | 1 | 27% | 0.5% | 3 |
9 | TRAINING ANTHROPOGENY | 1 | 27% | 0.5% | 3 |
10 | EXPT BIOMED MODELING | 1 | 33% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165925 | MYELIN ASSOCIATED GLYCOPROTEIN//L MAG//CEREBELLAR SOLUBLE LECTIN |
2 | 0.0000165443 | SIALYLTRANSFERASE//ST6GAL I//BETA GALACTOSIDE ALPHA 2 6 SIALYLTRANSFERASE |
3 | 0.0000135355 | NEUGCGM3//N GLYCOLYL GM3//CMP N ACETYLNEURAMINIC ACID HYDROXYLASE |
4 | 0.0000129193 | LAIR 1//CD300A//FCRL |
5 | 0.0000111678 | ACHATININ H//INFLUENZA C VIRUS//9 O ACETYLATED SIALOGLYCOCONJUGATES |
6 | 0.0000083613 | CD21//COMPLEMENT RECEPTOR 2//CR2 |
7 | 0.0000079928 | SHP 2//SHP 1//GAB1 |
8 | 0.0000076832 | RECEPTOR EDITING//SURROGATE LIGHT CHAIN//PRE B CELL RECEPTOR |
9 | 0.0000070804 | SHIP2//INOSITOL 5 PHOSPHATASE//SHIP1 |
10 | 0.0000065290 | ALCAM//CD166//CD6 |